Predictive Oncology Inc (NAS:POAI)
$ 0.8198 -0.0028 (-0.34%) Market Cap: 5.47 Mil Enterprise Value: 4.80 Mil PE Ratio: 0 PB Ratio: 2.73 GF Score: 52/100

Q3 2022 Predictive Oncology Inc Earnings Call Transcript

Nov 11, 2022 / 05:00PM GMT
Release Date Price: $5.16 (+5.74%)
Operator

Good day, ladies and gentlemen. Thank you for standing by. Welcome to the Predictive Oncology Third Quarter 2022 Earnings Conference Call. (Operator Instructions)

At this time, I would like to turn the conference over to Ms. Theresa Ferguson. Ma'am, please begin.

Theresa Ferguson
Senior Director of Marketing - Predictive Oncology

Thank you, and welcome, everyone. Thank you for dialing in. We are pleased to be here today, especially to introduce you to our new Chief Executive Officer, Raymond Vennare. He is going to share about his background in building, launching and leading biotech companies and how those insights will shape his vision for Predictive Oncology. Then we will hear from Dr. Pamela Bush, who will give us an update on sales and marketing. And then Bob Myers, our Chief Financial Officer, will share about our financials. So we appreciate you being here.

And real quickly, I will read about our forward-looking statement. Note that this call will be recorded and includes forward-looking statements within the meaning of the Private

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot